Medical Devices
-
Pulse Biosciences hires Liane Teplitsky as COO
The appointment gives a former Abbott leader oversight of efforts to bring a pulsed field ablation device to market.
By Nick Paul Taylor • April 10, 2026 -
E2 raises $80M to market thrombectomy platform
The funding round follows high-profile acquisitions by Boston Scientific and Stryker to pick up mechanical thrombectomy devices for blood clot removal.
By Susan Kelly • April 9, 2026 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
FDA, medtech industry near MDUFA VI agreement
The FDA said it intends to hire “substantial numbers” of medical device review staff as part of the agreement for the next medical device user fee amendments.
By Elise Reuter • April 9, 2026 -
CDRH targets hospital readmissions with home device innovation challenge
The center plans to pick nine devices to help support patients and caregivers after a hospital stay.
By Elise Reuter • April 9, 2026 -
Deep Dive
One year in: How medtech companies are coping with tariff challenges
A resilient medtech industry navigating the fallout from President Donald Trump’s trade wars is taking proactive steps to manage tariff costs as the administration’s policies continue to evolve.
By Susan Kelly • April 9, 2026 -
Philips warns not to use certain nebulizers in Trilogy Evo ventilator recall
Using non-pneumatic nebulizers with the ventilators can lead to under-delivery of therapy to patients, the company said.
By Elise Reuter • Updated April 9, 2026 -
Hologic hires former Baxter leader José Almeida as CEO
The company appointed Almeida as chief executive in conjunction with the completion of an $18.3 billion go-private deal.
By Nick Paul Taylor • April 8, 2026 -
Zimmer hires chief science, technology and medical affairs officer
Jonathan Vigdorchik, an orthopedic surgeon from the Hospital for Special Surgery, previously was chief medical technology adviser for the company.
By Elise Reuter • April 7, 2026 -
J&J launches enhanced PFA device in Europe
The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European Heart Rhythm Association annual meeting in Paris.
By Susan Kelly • April 7, 2026 -
UK steps up push to align medtech regulations with the US
Health regulators on both sides of the Atlantic are assessing alignment opportunities and exploring mutual recognition mechanisms.
By Nick Paul Taylor • April 7, 2026 -
VDyne secures FDA nod to start pivotal trial for tricuspid valve
With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is advancing a treatment to compete with Edwards Lifesciences’ Evoque system.
By Susan Kelly • April 6, 2026 -
Retrieved from Hologic on April 06, 2026
Hologic CEO Steve MacMillan to retire after go-private deal
The $18.3 billion acquisition by Blackstone and TPG is expected to close Tuesday.
By Elise Reuter • April 6, 2026 -
Boston Scientific closes buyout of Valencia Technologies
The deal positions Boston Scientific to compete with Medtronic for a market that analysts believe is highly under-penetrated.
By Nick Paul Taylor • April 6, 2026 -
Scientists urge EPA not to weaken ethylene oxide emissions standards
Scientists, clinicians and residents of communities near medical device sterilization plants called for the EPA not to weaken its oversight of ethylene oxide in a public hearing.
By Elise Reuter • April 3, 2026 -
Restore Robotics cleared to remanufacture 2 more da Vinci Xi instruments
The remanufacturer said it now has a total of four clearances for Intuitive Surgical da Vinci instruments from the Food and Drug Administration.
By Susan Kelly • April 3, 2026 -
Merit Medical acquires View Point for $140M
View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.
By Nick Paul Taylor • April 2, 2026 -
J&J’s Impella heart pump shows no patient benefit in 2 trials
Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat heart attack patients who don’t have cardiogenic shock.
By Susan Kelly • April 1, 2026 -
Deep Dive
‘Cracks show’ as CDRH staff contend with heavy workloads
Former device leaders said a culture of “fear and anxiety” has driven experienced staff from the Food and Drug Administration. An overburdened workforce has affected communications from the agency.
By Elise Reuter , Shaun Lucas • April 1, 2026 -
Distalmotion targets ASC robotic gynecology programs with FDA filing
The company is seeking clearance in additional gynecological indications to support outpatient use of its surgical robot.
By Nick Paul Taylor • April 1, 2026 -
Whoop raises $575M, adds Abbott as strategic investor
Whoop, the maker of a wearable wristband, plans to use the funds for global expansion and personalized health features.
By Elise Reuter • March 31, 2026 -
Medtronic wins CE mark for OmniaSecure defibrillation lead
The device maker designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.
By Nick Paul Taylor • March 31, 2026 -
Medtronic to study renal denervation combined with PCI
Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN trials that showed the procedure reduced hypertensive emergencies.
By Susan Kelly • March 31, 2026 -
Boston Scientific posts positive stroke prevention data for Watchman
The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and efficacy goals in the closely watched CHAMPION-AF study.
By Susan Kelly • March 30, 2026 -
Medtronic wins FDA clearance for robot in cranial, ENT surgeries
The surgical navigation and robotics system is part of the company’s push to expand its share of the $15 billion cranial and spinal technologies market.
By Nick Paul Taylor • March 30, 2026 -
Glucotrack plans US trial of implantable glucose monitor this year
Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.
By Elise Reuter • March 27, 2026